Continuous Glucose Monitoring and GLP-1 Therapy: What the Data Can Show You
What a continuous glucose monitor actually measures
One of the harder parts of any weight loss program is the guesswork. You are eating what you believe is healthy and taking your medication as prescribed, but you have little visibility into how your body is responding in real time. A continuous glucose monitor changes what you can see.
At Slender Me Medical we offer a medically supervised CGM program, and it comes up most often with patients on our semaglutide or tirzepatide programs. Here is what it does and what it does not do.
What is a CGM?
A continuous glucose monitor is a small wearable sensor, roughly the size of a quarter, worn on the back of the arm or abdomen. It measures glucose in the interstitial fluid continuously and sends readings to your phone every few minutes, day and night.
No finger sticks. It produces a continuous record of how glucose responds to food, activity, sleep, stress, and medication.
Why it comes up with GLP-1 patients
GLP-1 medications work in part by affecting blood glucose regulation and appetite. A CGM makes that process visible rather than inferred.
Individual food responses vary. Glycemic response to the same meal differs meaningfully between people. A food that barely moves one person's glucose can produce a substantial rise in another. A CGM shows your own pattern rather than a general guideline.
It provides feedback during titration. As dosing is adjusted, glucose patterns are one of several data points a provider can review alongside weight, symptoms, and lab work.
It can surface patterns worth investigating. Glucose variability sometimes reveals patterns that prompt further evaluation for insulin resistance or prediabetes. A CGM is not a diagnostic test for either condition, and any finding should be confirmed with appropriate lab work.
Some patients find the feedback useful for engagement. Seeing the effect of a specific meal in real time helps some people stay engaged with a program. This varies considerably by individual, and a CGM is a source of information rather than a treatment.
What a CGM will not do
A CGM does not cause weight loss. It provides data. Whether that data leads to different decisions depends on the person and on the clinical support around it. Evidence for CGM use in people without diabetes is still developing, and results vary.
It also produces a great deal of information, some of which is normal variation rather than a problem. That is part of why we run it as a supervised program rather than simply selling a sensor.
Who may want to consider one
A CGM may be worth discussing if you are on a semaglutide or tirzepatide program and want more information about your response, if you have been told you have prediabetes or insulin resistance, if you are trying to understand why progress has slowed, or if you find data helpful for staying engaged.
How our program works
- Purchase online or call (951) 898-8515
- We schedule your telehealth consultation
- Your provider evaluates candidacy and prescribes if appropriate
- Your sensor ships to you
- We guide you through setup, application, and interpreting the readings
- Clinical support continues throughout the program
A CGM requires a prescription. Not all patients will qualify.
Talk to us
Call Slender Me Medical at (951) 898-8515 to discuss whether a CGM makes sense alongside your program. We see patients in Corona and offer telehealth in California and Arizona.
A CGM is a prescription medical device. A telehealth consultation and provider approval are required, and not all patients will qualify. If lab work is required by your provider, it is billed separately. Device availability may vary. A CGM is not a diagnostic test for diabetes, prediabetes, or insulin resistance. Individual results vary. This article is educational and does not constitute medical advice.